Development Level

Tclin 3 | 602
Tbio 2 | 10,625
Tchem 1 | 1,890

Disease

Asthma 5 | 349
Cancer 5 | 2,346
Hypertension 5 | 287
Major Depressive Disorder 5 | 106
Schizophrenia 5 | 501
diabetes mellitus 5 | 1,663
psoriasis 5 | 6,685
Alzheimer's disease 4 | 644
Inflammatory bowel disease 4 | 142
Obesity 4 | 616
Rhinitis 4 | 46
Allergic hypersensitivity disease 3 | 123
Anxiety Disorders 3 | 37
Bipolar Disorder 3 | 266
Cerebrovascular disease 3 | 231
Cocaine-Related Disorders 3 | 88
Dermatitis 3 | 107
Endometriosis 3 | 535
Epicondylitis 3 | 19
Huntington's disease 3 | 72
Hyperglycemia 3 | 120
Irritable bowel syndrome 3 | 59
Metabolic syndrome X 3 | 155
Migraine 3 | 79
Narcolepsy 3 | 58
Neuropathy 3 | 210
Parkinson's disease 3 | 364
Urticaria 3 | 53
atypical teratoid / rhabdoid tumor 3 | 4,369
interstitial cystitis 3 | 2,299
invasive ductal carcinoma 3 | 2,950
pilocytic astrocytoma 3 | 3,086
Acne vulgaris 2 | 16
Adenocarcinoma 2 | 115
Alcohol dependence 2 | 107
Allergic rhinitis 2 | 91
Angioedema 2 | 36
Ankylosing spondylitis 2 | 138
Anorexia 2 | 15
Anxiety disorder 2 | 22
Arthritis 2 | 248
Arthritis, Experimental 2 | 39
Berylliosis 2 | 16
Breast cancer 2 | 3,094
Bronchitis 2 | 44
Chronic fatigue syndrome 2 | 29
Complex regional pain syndrome 2 | 12
Crohn's disease 2 | 304
Cystitis 2 | 16
Dementia 2 | 129
Depressive disorder 2 | 48
Diarrhea 2 | 155
Drug allergy 2 | 36
Edema 2 | 38
Epilepsy 2 | 346
Fibromyalgia 2 | 22
Heart disease 2 | 279
Hepatitis C 2 | 90
Hyperactive behavior 2 | 31
Hyperalgesia 2 | 71
Hyperinsulinism 2 | 63
Hypersensitivity 2 | 63
Hypertensive disease 2 | 193
Hypoglycemia 2 | 81
Hypotension 2 | 53
Infertility 2 | 163
Inflammation 2 | 109
Juvenile rheumatoid arthritis 2 | 104
Keratitis 2 | 42
Kidney disease 2 | 396
Lichen planus 2 | 17
Lung disease 2 | 132
Mammary Neoplasms 2 | 410
Multiple Sclerosis 2 | 498
Neuralgia 2 | 16
Neurogenic Inflammation 2 | 12
Osteoporosis 2 | 257
Pain 2 | 70
Pain agnosia 2 | 99
Pancreatitis 2 | 97
Peripheral Neuropathy 2 | 303
Pick disease 2 | 1,893
Pregnancy with abortive outcome 2 | 12
Psoriasis with arthropathy 2 | 11
Synovitis 2 | 38
Uveitis 2 | 103
astrocytoma 2 | 1,493
colon cancer 2 | 1,475
ductal carcinoma in situ 2 | 1,745
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
oligodendroglioma 2 | 2,849
osteosarcoma 2 | 7,933
ovarian cancer 2 | 8,484
pediatric high grade glioma 2 | 2,712
post-traumatic stress disorder 2 | 45
sarcoidosis 2 | 358
tuberculosis 2 | 1,557
ulcerative colitis 2 | 2,087

Tissue

Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Nervous System 6 | 18,561
Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 4 | 11,971
Nuclear Receptor 2 | 48

Grant Application

1Z01MH002585-18 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Pro-neuropeptide Y NPY Tbio Non-IDG -3.81741 7285.3 401
Tumor necrosis factor TNF Tclin Non-IDG -4.68994 50044.6 2261
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Progesterone receptor PGR Tclin Nuclear Receptor -3.91371 7682.6 1693
Protachykinin-1 TAC1 Tbio Non-IDG -4.12709 13651.7 395
Glucocorticoid receptor NR3C1 Tclin Nuclear Receptor -3.41185 2131.3 780